
ACNR
506 FOLLOWERS
Advances in Clinical Neuroscience and Rehabilitation (ACNR) is a UK-based, international, peer reviewed journal which aims to keep busy practicing specialists up-to-date with the latest advances in their fields, including areas of neurology and neuroscience outside their main area of sub-specialty interest.
ACNR
4d ago
Recent data from a large-scale comparative study indicate that RapidAI’s artificial intelligence (AI) platform demonstrates higher sensitivity in detecting large vessel occlusion (LVO) compared to Viz.ai’s software. The study, DUEL (Detection of LVO Using AI), represents the largest head-to-head evaluation to date, including 1,591 consecutive patients presenting with suspected stroke. Findings from this study, along...
The post Detecting large vessel occlusion (LVO) using AI appeared first on ACNR ..read more
ACNR
5d ago
The Children’s Hospital Los Angeles Comprehensive Epilepsy Center team recently performed its first thalamic responsive neurostimulation (RNS) procedure. This technology is placed deep in the thalamus, where it continually monitors a patient’s brain waves—and can stop seizures before they even start. Virendra R. Desai, MD, led the five-hour procedure, which was performed in a child...
The post Thalamic responsive neurostimulation (RNS) for epilepsy appeared first on ACNR ..read more
ACNR
1w ago
A research team at University College London (UCL) has identified a link between lifelong physical activity and neuroprotective changes in the brain, potentially reducing the risk of dementia. The findings, published in Brain Communications, come from Insight46, a longitudinal study funded by Alzheimer’s Research UK and the Medical Research Council (MRC), which tracks the health...
The post Impact of physical activity on Alzheimer’s disease appeared first on ACNR ..read more
ACNR
1w ago
Findings provide insight into its potential as a non-invasive therapy Researchers using intracranial electroencephalogram (EEG) recordings from deep within the brain found that meditation led to changes in activity in the amygdala and hippocampus, key brain regions involved in emotional regulation and memory. The study, conducted by researchers at the Icahn School of Medicine at...
The post Meditation induces changes in deep brain areas associated with memory and emotional regulation appeared first on ACNR ..read more
ACNR
1w ago
Visiting friends, attending parties and going to church may help keep your brain healthy, according to research conducted at Rush. The study, posted online in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, shows that frequent social activity may help to prevent or delay dementia in old age. “This study is a follow up...
The post Being social may delay dementia onset by five years appeared first on ACNR ..read more
ACNR
1w ago
A country-wide trial aiming to revolutionise how dementia is diagnosed using blood tests is now underway. The READ-OUT research team at Dementias Platform UK (DPUK) based at the University of Oxford and University of Cambridge, is part of the Blood Biomarker Challenge – a multi-million pound programme supported by Alzheimer’s Society, Alzheimer’s Research UK, National Institute...
The post Trial for blood tests to diagnose dementia accepts first participants appeared first on ACNR ..read more
ACNR
1w ago
The UK’s most powerful supercomputer, Isambard-AI, is set to become fully operational this summer in Bristol. UK Prime Minister Sir Keir Starmer recently announced plans to expand AI’s role in transforming public services, with a key focus on healthcare innovation. Transforming Neurological Research One of Isambard-AI’s key contributions will be in the field of neurology,...
The post £225m supercomputer using AI to develop new drugs and vaccines appeared first on ACNR ..read more
ACNR
1w ago
Motif Neurotech wins multimillion dollar UK Government award Motif Neurotech, a Houston-based neurotechnology company, have been selected by the UK’s Advanced Research and Invention Agency (ARIA) for a multimillion dollar award to support Motif’s development of a therapeutic brain-computer interface (BCI) technology to treat cognitive and psychiatric conditions. The award will fund development of a...
The post UK award to develop therapeutic brain-computer interface appeared first on ACNR ..read more
ACNR
1w ago
Safety labelling changes have been made in the US and UK for the Respiratory Syncytial Virus (RSV) vaccines Abrysvo (Pfizer Inc.) and Arexvy (GlaxoSmithKline Biologicals). Both vaccines will now include a warning about the potential risk of Guillain-Barré syndrome (GBS) following administration. Updated Safety Warnings: GBS is a rare but serious autoimmune disorder in which...
The post Updates to safety warnings for RSV vaccines due to Guillain-Barré Syndrome risk appeared first on ACNR ..read more
ACNR
1w ago
Pheno Therapeutics Limited announced on 14th January that it has received clinical trial authorisation (CTA) from the UK’s MHRA (Medicines and Healthcare products Regulatory Agency) for its lead candidate, PTD802. A selective GPR17 (G protein-coupled receptor 17) antagonist, PTD802 is a novel small molecule therapeutic designed to promote remyelination. Developed under an exclusive worldwide licence...
The post Clinical trial authorisation for multiple sclerosis therapeutic candidate appeared first on ACNR ..read more